Hua Medicine (HKSE:02552) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02552 Hua Medicine HKSE:02552
46 GF Score
Price HK$2.51
GF Value HK$8.74
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Hua Medicine Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:02552 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hua Medicine Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's Short Interest distribution charts can be found below:

* The bar in red indicates where Hua Medicine's Short Interest falls into.


HKSE:02552
46GF Score
Hua Medicine HKSE:02552
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hua Medicine (HKSE:02552) Overvalued in 2026?

Based on GuruFocus' analysis, Hua Medicine stock appears to be undervalued. The current stock price of HK$2.51 is trading 71.3% below its estimated GF Value™ of HK$8.74. GuruFocus considers Hua Medicine to be Possible Value Trap.

Key valuation signals for HKSE:02552:

  • Short Interest:
  • GF Value™: HK$8.74 vs. price of HK$2.51 (71.3% below fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the HKSE:02552 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hua Medicine Business Description

Other Exchanges HUMDF:USA
Address Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin (HMS5552), for the treatment of Type 2 diabetes. Dorzagliatin is a first-in-class glucokinase activator, or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The group majorly operates and generates the majority of its revenue from the PRC.
46GF Score

Get the complete analysis for HKSE:02552

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.51
Price
HK$8.74
GF Value